Avidity Biosciences, Inc. (RNA)

Avidity Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	254.2	219.87	185.08	340.4	320.45	321.46
Short-Term Investments	1,126	1,282	410.27	270.33	85.1	6.68
Cash & Short-Term Investments	1,380	1,501	595.35	610.73	405.54	328.14
Cash Growth	50.66%	152.20%	-2.52%	50.59%	23.59%	246.95%
Accounts Receivable	-	-	1.11	2.36	0.9	1.2
Other Receivables	36.58	28.22	7.52	1.51	-	-
Receivables	36.58	28.22	8.62	3.88	0.9	1.2
Prepaid Expenses	18.52	12.57	7.33	8.34	4.7	2.34
Total Current Assets	1,435	1,542	611.31	622.94	411.14	331.68
Property, Plant & Equipment	20.57	18.29	16.65	15.01	15.59	1.92
Other Long-Term Assets	3.53	3.32	0.6	0.85	0.85	0.3
Total Assets	1,459	1,564	628.56	638.8	427.58	333.9
Accounts Payable	6.63	8.46	8.81	4.64	2.81	7.75
Accrued Expenses	60.37	64.73	39.87	39.13	20.22	3.15
Current Portion of Leases	3.88	3.84	3.64	3.11	1.77	-
Current Unearned Revenue	13.98	20.99	28.37	5.04	4.86	3.69
Total Current Liabilities	84.87	98.02	80.68	51.91	29.66	14.59
Long-Term Leases	2.09	2.96	6.21	7.58	9.96	0.94
Long-Term Unearned Revenue	43.4	37.96	40.9	1.24	6.53	12.15
Total Liabilities	130.35	138.94	127.79	60.73	46.15	27.68
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	2,335	2,315	1,071	939.31	566.16	372.76
Retained Earnings	-1,009	-893.07	-570.76	-358.54	-184.55	-66.54
Comprehensive Income & Other	2.77	2.9	0.13	-2.7	-0.19	-0.01
Total Common Equity	1,329	1,425	500.76	578.08	381.43	306.22
Shareholders' Equity	1,329	1,425	500.76	578.08	381.43	306.22
Total Liabilities & Equity	1,459	1,564	628.56	638.8	427.58	333.9
Total Debt	5.97	6.8	9.85	10.69	11.73	0.94
Net Cash (Debt)	1,374	1,495	585.5	600.04	393.81	327.2
Net Cash Growth	51.52%	155.29%	-2.42%	52.37%	20.36%	265.01%
Net Cash Per Share	11.25	13.40	8.02	11.50	9.51	15.10
Filing Date Shares Outstanding	120.54	120.21	79.72	70.81	47.75	37.58
Total Common Shares Outstanding	120.51	119.89	79.28	69.77	47.75	37.57
Working Capital	1,350	1,444	530.63	571.03	381.48	317.09
Book Value Per Share	11.03	11.89	6.32	8.29	7.99	8.15
Tangible Book Value	1,329	1,425	500.76	578.08	381.43	306.22
Tangible Book Value Per Share	11.03	11.89	6.32	8.29	7.99	8.15
Machinery	16.94	16.42	13.31	9.13	6.29	3.03
Construction In Progress	7.19	3.96	-	-	-	-
Leasehold Improvements	0.29	0.29	0.29	0.25	0.25	0.42

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q